81
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Platelet polymorphisms: Frequency distribution and association with coronary artery disease in an Indian population

, , , , , , & show all
Pages 85-91 | Received 16 Mar 2010, Accepted 06 Sep 2010, Published online: 29 Oct 2010

References

  • Enas EA. Coronary artery disease epidemic in Indians: A cause for alarm and call for action. J Indian Med Assoc 2000; 98: 694–702
  • Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115–126
  • Voetsch B, Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 2004; 24: 216–229
  • Meisel C, Lopez JA, Stangl K. Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn-Schmiedeberg's Arch Pharmacol 2004; 369: 38–54
  • Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleate cell. Nucleic Acids Res 1988; 16: 1219
  • Anderson JF, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J, Carlquist JF. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 1999; 33: 727–733
  • Murata M, Matsubara Y, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 1997; 96: 3281–3286
  • Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (hindIII/AluI), T/G + 1689 (AvaII), and BclI (B-fibrinogen) and TaqI (a-fibrinogen), and their detection by PCR. Human Mutat 1994; 3: 79–81
  • Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G−455 → A) in the b-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997; 99: 3034–3039
  • Blake GJ, Schmitz C, Lindpaintner K, Ridker PM. Mutation in the promoter region of the β-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 2001; 22: 2262–2266
  • Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: Identification of polymorphisms at positions Aα312 and Bβ448. Blood 1993; 82: 2117–2124
  • Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999; 93: 2449–2453
  • Zhan M, Zhou Y, Han Z. Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China. Chinese Med J 2003; 116: 1707–1710
  • Kulkarni B, Mohany D, Ghosh K, Pawar A, Khare A. Frequency distribution of antigens in the human platelet antigen-1system in the western Indian population. Transfusion 2002; 42: 317–320
  • Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. PL(A1/A2) polymorphism of platelet glycoprotein IIIa and the risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385–388
  • Gonzalez-Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 1998; 92: 2771–2776
  • Dinauer DM, Friedman KD, Hessner MJ. Allelic distribution of the glycoprotein Ia (α2-integrin) C807T/G873A dimorphisms among Caucasian venous thrombosis patients and six racial groups. Br J Hemat 1999; 107: 563–565
  • Humphries SE, Cook M, Dubowitz M, Striling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of fibrinogen concentrations. Lancet 1987; i: 1452
  • Liu Y, saha N, Heng CK, Hong S, Low PS. Fibrinogen genotypes (a and b) are associated with plasma fibrinogen levels in Chinese. JMG 2001; 38: e31
  • Kain K, Blaxill JM, Catto AJ, Grant PJ, Carter AM. Increased fibrinogen levels among South Asians versus Whites in the United Kingdom are not explained by common polymorphisms. Am J Epidemiol 2002; 156: 174–179
  • Yang Z, Li F, Liu G, Cai W, Ling G. The study of beta-fibrinogen gene −455 G/A, −148 C/T, 448 G/A polymorphisms and their association with plasma fibrinogen levels. Zhonghua Xue Ye Xue Za Zhi 2000; 21: 463–465
  • Zito F, Castelnuovo AD, Amore C, D’Orazio A, Donati MB, Iacoviello L. BclI polymorphism in the fibrinogen β-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case- control study in a sample of GISSI-2 patients. Arterioscler Thromb Vasc Biol 1997; 17: 3489–3494
  • Carter AM, Ossei-Gerning N, Wilson IJ, Grant PJ. Association of the platelet PIA polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bb448 with myocardial infarction and extent of coronary artery disease. Circulation 1997; 96: 1424–1431
  • Ni Y, Hu D, Yu H, Li C, Liu W, Wang H, Li L. Association of genetic polymorphisms in the fibrinogen and platelet glycoprotein genes with unstable angina in Chinese patients. Clin Cardiol 2004; 27: 455–458
  • Carter AM, Catto AJ, Kohler HP, Ariens RAS, Stickland MH, Grant PJ. α-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 2000; 96: 1177–1179
  • de Maat MP, Kastelein JJ, Jukema JW, Zwinderman AH, Jansen H, Groenemeier B, Bruschke AV, Kluft C. -455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: Proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol 1998; 18: 265–271
  • Green F, Hamsten A, Blombäck M, Humphries S. The role of b-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915–920
  • Scarabin P, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the b-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction: The ECTIM study. Arterioscler Thromb 1993; 13: 886–891
  • van der Bom, de Knijff P, Haverkate F et al. Tissue plasminogen activator and risk of myocardial infarction Circulation 1997;95:2623–2627.
  • Ridker PM, Baker MT, Hennekens CH, Stampfer MJ, Vaughan DE. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. Arterioscler Thromb Vasc Biol 1997; 17: 1687–1690
  • Makalowski W, Mitchell GA, Labuda D. Alu sequences in the coding regions of mRNA: A source of protein variability. Trends Genet 1994; 10: 188–193
  • Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction. Chin Med J 2001; 114: 266–269
  • Ranjith N, Pedgoraro RJ, Rom L. Hemostatic gene polymorphisms in young Indian Asian subjects with acute myocardial infarction. Med Sci Monit 2003; 9: CR417–421
  • Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367: 651–658
  • Ashavaid TF, Shalia KK, Kondkar AK, Todur SP, Nair KG, Nair SR. Gene polymorphism and coronary risk factors in Indian population. Clin Chem Lab Med 2002; 40: 975–985
  • Ashavaid TF, Shalia KK, Dalal J. ACE and AT1R gene polymorphisms and hypertension in Indian population. J Clin Lab Anal 2000; 14: 230–237
  • Nair KG, Nair SR, Ashavaid TF, Dalal JJ, Eghlim FF. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population. J Assoc Phys Ind 2002; 50: 9–15

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.